These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10319057)

  • 1. Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time.
    Faul JL; Leonard CT; Burke CM; Tormey VJ; Poulter LW
    Thorax; 1998 Sep; 53(9):753-61. PubMed ID: 10319057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma.
    Ward C; Pais M; Bish R; Reid D; Feltis B; Johns D; Walters EH
    Thorax; 2002 Apr; 57(4):309-16. PubMed ID: 11923548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma.
    Pavord I; Woodcock A; Parker D; Rice L;
    Respir Res; 2007 Sep; 8(1):67. PubMed ID: 17897478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related response to inhaled fluticasone propionate in patients with methacholine-induced bronchial hyperresponsiveness: a double-blind, placebo-controlled study.
    Noonan MJ; Chervinsky P; Wolfe J; Liddle R; Kellerman DJ; Crescenzi KL
    J Asthma; 1998; 35(2):153-64. PubMed ID: 9576141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in airway inflammation and lung function during corticosteroid therapy for atopic asthma.
    Faul JL; Demers EA; Burke CM; Poulter LW
    Chest; 2002 May; 121(5):1414-20. PubMed ID: 12006422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhaled steroids on airway hyperresponsiveness, sputum eosinophils, and exhaled nitric oxide levels in patients with asthma.
    van Rensen EL; Straathof KC; Veselic-Charvat MA; Zwinderman AH; Bel EH; Sterk PJ
    Thorax; 1999 May; 54(5):403-8. PubMed ID: 10212103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of short-term treatment with low-dose inhaled fluticasone propionate on airway inflammation and remodeling in mild asthma: a placebo-controlled study.
    Olivieri D; Chetta A; Del Donno M; Bertorelli G; Casalini A; Pesci A; Testi R; Foresi A
    Am J Respir Crit Care Med; 1997 Jun; 155(6):1864-71. PubMed ID: 9196087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma.
    Bootsma GP; Dekhuijzen PN; Festen J; Mulder PG; van Herwaarden CL
    Thorax; 1995 Oct; 50(10):1044-50. PubMed ID: 7491551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of fluticasone propionate on methacholine dose-response curves in nonsmoking atopic asthmatics.
    Overbeek SE; Rijnbeek PR; Vons C; Mulder PG; Hoogsteden HC; Bogaard JM
    Eur Respir J; 1996 Nov; 9(11):2256-62. PubMed ID: 8947069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the addition of montelukast to inhaled fluticasone propionate on airway inflammation.
    O'Sullivan S; Akveld M; Burke CM; Poulter LW
    Am J Respir Crit Care Med; 2003 Mar; 167(5):745-50. PubMed ID: 12480610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of low-dose inhaled fluticasone propionate on exhaled nitric oxide in asthmatic patients and comparison with oral zafirlukast.
    Lanz MJ; Eisenlohr C; Llabre MM; Toledo Y; Lanz MA
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):283-8. PubMed ID: 11686419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of fluticasone propionate on functional status and sleep in children with asthma and on the quality of life of their parents.
    Mahajan P; Pearlman D; Okamoto L
    J Allergy Clin Immunol; 1998 Jul; 102(1):19-23. PubMed ID: 9679843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluticasone propionate and bronchial hyperresponsiveness in childhood asthma.
    Direkwattanachai C; Limkittikul K; Kraisarin C; Sasisakulporn C; Benjaponpitak S
    Asian Pac J Allergy Immunol; 1999 Jun; 17(2):63-7. PubMed ID: 10466540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
    Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
    Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of varying doses of fluticasone propionate on the physiology and bronchial wall immunopathology in mild-to-moderate asthma.
    O'Sullivan S; Cormican L; Murphy M; Poulter LW; Burke CM
    Chest; 2002 Dec; 122(6):1966-72. PubMed ID: 12475834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
    Hattotuwa KL; Gizycki MJ; Ansari TW; Jeffery PK; Barnes NC
    Am J Respir Crit Care Med; 2002 Jun; 165(12):1592-6. PubMed ID: 12070058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of different dosage schedules of inhaled fluticasone propionate on peripheral blood cytokine concentrations in childhood asthma.
    Visser MJ; Postma DS; Brand PL; Arends LR; Duiverman EJ; Kauffman HF
    Clin Exp Allergy; 2002 Oct; 32(10):1497-503. PubMed ID: 12372131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low- and high-dose fluticasone propionate in asthma; effects during and after treatment.
    Gershman NH; Wong HH; Liu JT; Fahy JV
    Eur Respir J; 2000 Jan; 15(1):11-8. PubMed ID: 10678614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of fluticasone propionate in COPD patients with bronchial hyperresponsiveness.
    Verhoeven GT; Hegmans JP; Mulder PG; Bogaard JM; Hoogsteden HC; Prins JB
    Thorax; 2002 Aug; 57(8):694-700. PubMed ID: 12149529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained reduction in bronchial hyperresponsiveness with inhaled fluticasone propionate within three days in mild asthma: time course after onset and cessation of treatment.
    Sovijärvi AR; Haahtela T; Ekroos HJ; Lindqvist A; Saarinen A; Poussa T; Laitinen LA
    Thorax; 2003 Jun; 58(6):500-4. PubMed ID: 12775860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.